Health Conditions

References

American Lung Association Fact Sheet. Respiratory Syncytial Virus. Available at: http://www.lungusa.org/diseases/rsvfac.html. Accessed October 11, 2007.

Hall CB. Respiratory Syncytial Virus and Parainfluenza Virus. NEJM 2001; 344:1917-1928.

CDC-Respiratory and Enteric Virus Branch. Respiratory Syncytial Virus. Available at: . http://www.cdc.gov/search.do?action=search&queryText=RSV&x=18&y=5.Accessed October 11, 2007.

Glover ML and Reed MD. Lower respiratory tract infections. In: Dipiro J et al. Pharmacotherapy: A pathophysiologic approach. 6th edition. New york: McGraw-Hill 2005; 1943-1962.

MedlinePlus.gov. Respiratory Syncytial Virus. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/001564.htm. Accessed October 11, 2007.

Association of Cancer Online Resources. Clinical Trials: Disease Specific Respiratory Syncytial Virus. July 2002. Available at: http://www.acor.org

American Society for Microbiology. Abandoned Antiviral Could Lead to Better RSV Treatments. ASM News 2002;68(4). Available at: http://www.asmusa.org/memonly/asmnews/apr02/topic1.htm

Applied Molecular Evolution. Safe Harbor Statement. Available at: http://www.AMEvolution.com

Brady MT. Respiratory syncytial virus. Burg FD, Wald ER, Ingelfinger JR, et al. Gellis & Kagan's Current Pediatric Therapy. 16th edition. Philadelphia: W.B. Saunders Company;1999:130-132.

Cincinnati Children's Hospital Medical Center. Conditions and diagnoses: Respiratory Syncytial Virus. Available at: http://www.cincinnatichildrens.org/Health_Topics. Accessed October 11, 2007.

Dolin R. Common viral respiratory infection. Fauci AS, Braunwald E, Isselbacher KJ, et al. Harrison's Principles of Internal Medicine. 14th edition. New York: McGraw-Hill;1998:1100-1105.

QXHealth. Pharma Product Drug Delivery. Available at: http://www.qxhealth.com/Licensing/CFML/Details.cfm-sum_ID=208

Saxon M. Interscience Conference on Antimicrobial Agents and Chemotherapy-40th Meeting (Part IX). Current Drugs: Headline News. September 2000. Available at: http://www.cureent-drugs.com/NEWS/ICAAC40R9.htm

The Center for Disease Control and Prevention (CDC). Issues in Healthcare Settings: RSV infection. January 1997. Available at: http://www.cdc.gov/ncidod/hip/abc/facts31.htm. Accessed Oct 10, 2002 and May 25, 2006.

The Center for Disease Control and Prevention (CDC). RSV Infection. Available at: http://www.cdc.gov/ncidod/hip/pneumonia/1_rsv.htm. Accessed October 11, 2007.

The Center for Disease Control and Prevention (CDC). Respiratory Syncytial Virus Activity-United States, 2000-01 Season. January 2002. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5102a2.htm. Accessed Oct 25, 2002 and May 25, 2006.

Mott Health Topics: Respiratory Sycytial Virus. Available at http://www.med.umich.edu/1libr/pa/pa_rsv_hhg.htm. Accessed October 11, 2007.

Krilov, LR. Respiratory Syncytial Virus Infection. Available at: http://www.emedicine.com/ped/topic2706.htm. Accessed Oct 25, 2002 and May 25, 2006.

Respigam Package Insert. Gaithersburg, MD: MedImmune, Inc.; 2000 May.

WU H, Pfarr DS, et all; Development of motavizumab, an ultra-potent antibody for the prevention of respiratoy syncytial virus infection in the upper and lower respiratory tract: J Mol Biol, May 4 2007;368(3):652-65

Clinical trials.gov: Respiratory Syncytial virus Accessed Oct 11th 2007

<< Back